.. raw:: html

    Here is some rather troubling news for pharmaceutical and life sciences supply chains. FDA News and other India news outlets report that 200 drug manufacturers have been now cited by India’s national drug regulator for noncompliance and “high risk” for quality control lapses as part of an initial effort to crackdown on the country’s pharmaceutical [&#8230;]<img alt="" height="1" src="http://feeds.feedburner.com/~r/Supply-Chain-Matters/~4/T0LXRNXMofc" width="1" />
